Redox (RDX) AGM 2025 summary

Opening remarks and agenda

• Welcomed attendees in-person and online, introduced board members, executives, auditors, and outlined the agenda including presentations, Q&A, and formal resolutions.

Financial performance review

• FY25 sales revenue reached $1.244b, a 9.4% increase versus the prior period, with gross profit up 1.0% and a 45.3% conversion margin.

• Gross profit margin was 21.6%, within the historical range.

• Cash or cash equivalents stood at AUD 124 million ($123.8m), with zero net debt and unused debt facilities of AUD 185 million at year-end.

• Price deflation was a headwind, but tonnages and volume growth remained strong despite subdued demand.

• Inventory increase attributed to acquisitions and timing, with most goods pre-sold and risk considered low.

• Crop Production & Protection sales rose 30% due to robust demand and product integration.

Board and executive committee updates

• Board operates harmoniously, aligning with company culture and supporting strong results.

• CEO and executive team praised for leadership, openness to new ideas, and flexibility; presented on operational and strategic progress.

• Board composition included re-election of directors and grant of performance rights to executive directors.

• Board diversity and refreshment are ongoing priorities, with implementation of employee survey recommendations.